breast cancer

[sanjeev_43]

someone helps me knowing benefit of Mammaprint/Blueprint. These are tests recommended for early stage1 -2 breast cancer. where these are available in India.

[kontak TeamBCI]

Hi sanjeev welcome to our forum. Pl do share the reports so that you can receive a proper reply to your querries. Where are you from?

Also see that you introduce yourself

[manish_vkg TeamBCI]

Hi snjeev, as kontak said plz share the diagnosis...The MammaPrint test analyzes 70 genes to see how active they are and then calculates either a high-risk or a low-risk recurrence score. Research suggests the MammaPrint test eventually may be used more to make treatment decisions based on the recurrence risk of early-stage hormone-receptor-positive or hormone-receptor-negative disease.

[roxboxfox RadiationOncologist]

Mammaprint and Oncotype Dx not done in INDIA.

For Mammaprint:

I ve heard someone from Delhi has negotiated some contract and they collect the specimen and export it to Outside...? Switzerland or US

Cost : 1.9 lakhs

Oncotype DX: Cost : 2.69 lakhs ( $ 4510 – 8% discount)

Medilinks Inc.

803, Naman Midtown, B wing

8th Floor, Senapati Bapat Marg,

Elphinstone, Mumbai – 400013

Contact Medilinks India

Customer Care Tel: [phone]

: [phone] / 07

Email: [e-mail]

They send specimen to Genomic Health

San Francisco, CA USA

The Oncotype DX Breast Cancer Assay is clinically validated for predicting risk of recurrence and benefit of chemotherapy in women with stage I or II, node negative, and estrogen receptor positive breast cancer who will be treated with tamoxifen. Post-menopausal women recently diagnosed with node-positive, estrogen-receptor-positive breast cancer may also be appropriate candidates for the Oncotype DX test.